| |
|
|
|
TRACON Pharmaceuticals Inc.  
|
|
0.52 0 (0%) |
08-23 15:55 |
|
Open: |
0.5 |
Pre close: |
0.52 |
Target:
|
0.68
|
|
High: |
0.532 |
Low: |
0.5 |
Resistance:
|
0.58
0.68
|
|
Volume: |
66,829 |
Market Cap: |
16M |
Support:
|
0.47
0.40
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.52
 |
MACD |
MACD(12,26):
|
-0.01  |
|
MA(20): |
0.48 |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
0.67 |
Stochastic Oscillator |
%K(14,3):
|
75.62 |
|
MA(250): |
1.09 |
%D(3): |
76.04 |
|
Average Volume(K) |
3-Month: |
18534
|
52-Week |
High:
|
2.35 |
|
10-Days: |
8687 |
Low: |
0.40 |
|
RSI |
RSI(14):
|
51.34 |
Change(%): |
-74.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.132 |
Return on Equity (ttm) |
-118.0 |
Shares Out. (M) |
29.94 |
|
EPS Est. Current Year |
-1.570 |
Return on Assets (ttm) |
-43.0 |
Shares Float (M) |
15.36 |
|
EPS Est. Next Year |
-1.830 |
PEG Ratio |
0.00 |
% Held by Insiders |
8.89 |
|
EPS Est. Next Quarter |
-0.490 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
67.23 |
|
Forward EPS |
-1.527 |
Gross Profit (p.s.) |
-0.698 |
Shares Short (K) |
763 |
|
Book Value (p.s.) |
0.500 |
EBITDA (p.s.) |
-1.125 |
P/E |
-0.46 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.04 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-31.58 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-20.96 |
P/CF |
-0.49 |
|
|
|
|
|
|
